BB Biotech as of Dec. 31, 2012
Portfolio Holdings for BB Biotech
BB Biotech holds 19 positions in its portfolio as reported in the December 2012 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Celgene Corporation | 20.4 | $210M | 2.7M | 78.47 | |
Gilead Sciences (GILD) | 14.3 | $148M | 2.0M | 73.45 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 8.3 | $85M | 2.0M | 41.90 | |
Incyte Corporation (INCY) | 8.3 | $85M | 5.1M | 16.61 | |
ISIS Pharmaceuticals | 8.2 | $84M | 8.0M | 10.44 | |
Ariad Pharmaceuticals | 4.8 | $50M | 2.6M | 19.18 | |
Medivation | 4.8 | $49M | 962k | 51.16 | |
ImmunoGen (IMGN) | 4.4 | $45M | 3.6M | 12.75 | |
Alexion Pharmaceuticals | 4.1 | $42M | 450k | 93.74 | |
Onyx Pharmaceuticals | 4.0 | $41M | 547k | 75.53 | |
Medicines Company | 3.7 | $38M | 1.6M | 23.97 | |
Halozyme Therapeutics (HALO) | 3.6 | $37M | 5.6M | 6.71 | |
BioMarin Pharmaceutical (BMRN) | 3.5 | $36M | 734k | 49.20 | |
Theravance | 1.9 | $20M | 888k | 22.24 | |
Endocyte | 1.8 | $19M | 2.1M | 8.98 | |
Achillion Pharmaceuticals | 1.3 | $14M | 1.7M | 8.01 | |
Optimer Pharmaceuticals | 1.3 | $13M | 1.4M | 9.05 | |
Dendreon Corporation | 0.8 | $8.1M | 1.5M | 5.29 | |
Idenix Pharmaceuticals | 0.6 | $6.1M | 1.3M | 4.85 |